How Much Bacteriostatic Water for KLOW Blend? (Chart)
To reconstitute an 80mg KLOW Blend vial, add between 1.0 mL and 5.0 mL of bacteriostatic water depending on your target experimental concentration, with a standard 2.0 mL dilution yielding 40 mg/mL total peptide concentration. This reference guide outlines exact reconstitution volumes, volumetric arithmetic, and laboratory aliquoting protocols for in vitro research.
Quick answer
To reconstitute an 80mg KLOW Blend vial, add between 1.0 mL and 5.0 mL of bacteriostatic water depending on your target experimental concentration, with a standard 2.0 mL dilution yielding 40 mg/mL total peptide concentration. This reference guide outlines exact reconstitution volumes, volumetric arithmetic, and laboratory aliquoting protocols for in vitro research.
Key takeaways
- Determining how much bacteriostatic water for KLOW blend reconstitution depends entirely on the required volumetric concentration for your specific laboratory assays.
- The KLOW Blend is a specialized multi-component research formulation engineered for comparative in vitro investigation.
- The following volumetric chart provides exact concentration outputs for an 80 mg total mass KLOW Blend vial across standard diluent additions of 1.0 mL, 2.0 mL, 3.0 mL, and 5.0 mL of bacteriostatic water.
- Calculating the final concentration of a reconstituted research peptide relies on the fundamental mass concentration formula: C = M / V, where C represents final concentration in mg/mL, M represents peptide mass in milligrams (mg), and V represents diluent volume in milliliters (mL).
Immediate Dilution Guidelines for KLOW Blend Reconstitution
Determining how much bacteriostatic water for KLOW blend reconstitution depends entirely on the required volumetric concentration for your specific laboratory assays. Standard laboratory protocols for reconstituting an 80 mg multi-peptide vial typically utilize 1.0 mL, 2.0 mL, 3.0 mL, or 5.0 mL of sterile bacteriostatic water (0.9% benzyl alcohol preserved). A volume of 2.0 mL is the most widely adopted baseline in analytical settings, transforming the 80 mg lyophilized cake into a manageable working solution of 40 mg/mL total peptide concentration.
When working with composite research formulations such as the KLOW Blend 80mg, researchers must account for the total combined mass of all four component peptides: GHK-Cu, TB-500, BPC-157, and KPV. Adding smaller volumes of diluent (e.g., 1.0 mL) produces a highly concentrated solution of 80 mg/mL, which is useful when micro-volumetric additions are necessary for cellular microplate assays. Conversely, adding larger diluent volumes (e.g., 5.0 mL) reduces the overall concentration to 16 mg/mL, allowing for higher precision when pipetting larger fluid volumes in benchtop assays.
To ensure precise execution across diverse experimental designs, researchers can cross-reference calculations using our interactive reconstitution calculator. This tool helps prevent volumetric calculation errors prior to handling delicate research peptides in the laboratory environment.
KLOW Blend Mass Composition & Stoichiometric Ratios
The KLOW Blend is a specialized multi-component research formulation engineered for comparative in vitro investigation. Each high-purity vial contains a combined mass of 80 mg of lyophilized active ingredients, pre-formulated in precise stoichiometric ratios to facilitate standardized baseline research into cellular signaling, tissue architecture, and inflammatory pathways.
The total 80 mg mass consists of 50 mg of GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex), 10 mg of TB-500 (Thymosin Beta-4 fragment), 10 mg of BPC-157 (Body Protection Compound 157 pentapeptide), and 10 mg of KPV (Lysine-Proline-Valine tripeptide). Because these four distinct sequence chains coexist within a single lyophilized matrix, any diluent added to the vial dilutes all four constituents proportionally.
Understanding this compound ratio is essential for accurate assay dosing. For instance, in a 2.0 mL reconstitution yielding a total concentration of 40 mg/mL, the individual constituent concentrations are 25 mg/mL GHK-Cu, 5 mg/mL TB-500, 5 mg/mL BPC-157, and 5 mg/mL KPV. Purity and mass verification for each lot are documented on our official third-party certificate of analysis, ensuring analytical consistency across replicate experimental setups.
Comprehensive Reconstitution Volumetric Reference Chart
The following volumetric chart provides exact concentration outputs for an 80 mg total mass KLOW Blend vial across standard diluent additions of 1.0 mL, 2.0 mL, 3.0 mL, and 5.0 mL of bacteriostatic water. Researchers should select diluent volumes based on the resolution limit of their precision pipettes and the concentration limits dictated by their assay media.
| Diluent Volume (BAC Water) | Total Blend Concentration | GHK-Cu (50mg Mass) | TB-500 (10mg Mass) | BPC-157 (10mg Mass) | KPV (10mg Mass) | |---|---|---|---|---|---| | 1.0 mL | 80.0 mg/mL | 50.0 mg/mL | 10.0 mg/mL | 10.0 mg/mL | 10.0 mg/mL | | 2.0 mL | 40.0 mg/mL | 25.0 mg/mL | 5.0 mg/mL | 5.0 mg/mL | 5.0 mg/mL | | 3.0 mL | 26.67 mg/mL | 16.67 mg/mL | 3.33 mg/mL | 3.33 mg/mL | 3.33 mg/mL | | 5.0 mL | 16.0 mg/mL | 10.0 mg/mL | 2.0 mg/mL | 2.0 mg/mL | 2.0 mg/mL |
When choosing the reconstitution volume, researchers must consider the solubility envelope of high-mass copper complexes like GHK-Cu. While an 80 mg/mL concentration (1.0 mL fill) is achievable, it requires gentle mechanical agitation and ambient temperature equilibrium to reach complete dissolution without peptide precipitation.
Concentration Arithmetic and Volumetric Calculation Formulas
Calculating the final concentration of a reconstituted research peptide relies on the fundamental mass concentration formula: C = M / V, where C represents final concentration in mg/mL, M represents peptide mass in milligrams (mg), and V represents diluent volume in milliliters (mL).
For an 80 mg KLOW Blend vial reconstituted with 2.0 mL of bacteriostatic water, the arithmetic proceeds as follows: C_total = 80 mg / 2.0 mL = 40 mg/mL. To calculate the individual constituent concentrations, apply the formula to each specific peptide mass within the vial: C_GHK-Cu = 50 mg / 2.0 mL = 25 mg/mL; C_TB-500 = 10 mg / 2.0 mL = 5 mg/mL; C_BPC-157 = 10 mg / 2.0 mL = 5 mg/mL; C_KPV = 10 mg / 2.0 mL = 5 mg/mL.
If a secondary serial dilution is required for cell culture applications (e.g., micromolar or nanomolar working solutions), the standard C1V1 = C2V2 dilution formula should be applied using stock culture media. Reviewing our full catalog of catalog of research peptides provides additional mass specifications for standalone peptides if isolated component controls are needed during comparative testing.
Comparative Analysis: Multi-Peptide Blends vs. Standalone Monopeptides
In laboratory research, utilizing pre-formulated multi-peptide blends like KLOW Blend presents distinct volumetric and operational workflows compared to evaluating standalone peptides. When conducting tissue culture assays or cell migration studies, investigators frequently compare multi-component mixtures against isolated controls such as BPC-157, TB-500, GHK-Cu, or KPV.
The primary advantage of multi-peptide blends is the reduction of pipetting steps and vessel handling, which minimizes potential contamination vectors and prep-time variability. However, reconstituting a 4-in-1 blend requires careful attention to solvent volume, as all four sequences are bound to the same final liquid volume. Standalone monopeptides allow independent concentration tuning per compound but require multiple individual reconstitutions and pipetting transfers.
Preclinical literature demonstrates that combined signaling pathways (e.g., angiogenic regulation by BPC-157 and actin remodeling by TB-500) may display distinct kinetic profiles when introduced simultaneously versus sequentially in cell culture models. Utilizing fixed-ratio blends ensures high reproducibility across experimental replicates.
Step-by-Step Laboratory Reconstitution Protocol
To maintain sterility, chemical integrity, and complete dissolution during reconstitution, bench researchers should strictly adhere to standard aseptic laboratory techniques inside a certified laminar flow hood.
1. Swab the rubber stoppers of both the 80 mg KLOW Blend vial and the bacteriostatic water vial with a fresh 70% isopropyl alcohol wipe and allow them to air-dry completely. 2. Using a sterile polypropylene syringe fitted with a high-gauge needle (e.g., 21G–25G), draw the target volume of bacteriostatic water (e.g., 2.0 mL) from the diluent vial. 3. Insert the needle through the center of the KLOW Blend rubber septum at a 45-degree angle, pointing the needle tip toward the inner glass wall of the vial. 4. Slowly depress the plunger to allow the bacteriostatic water to stream down the glass wall rather than squirting directly onto the lyophilized cake, preventing structural shearing of delicate peptide bonds. 5. Equalize internal vial pressure by drawing back an equivalent volume of air into the syringe prior to removing the needle, preventing pressure-induced jetting or septum leakage. 6. Gently swirl the vial in a smooth circular motion. Never shake or vortex peptide solutions violently, as mechanical shear stress can disrupt tertiary folding and induce peptide aggregation.
For additional foundational technical guides on handling lyophilized proteins, consult our comprehensive research peptides library.
Laboratory Aliquoting and Reconstituted Storage Protocols
Once fully dissolved, reconstituted KLOW Blend must be handled under strict thermal controls to prevent enzyme-catalyzed degradation and hydrolysis. Unopened, lyophilized vials maintain high stability when stored at -20°C or -80°C. Once reconstituted with bacteriostatic water (containing 0.9% benzyl alcohol as a bacteriostatic preservative), stock solutions can be maintained at 2°C to 8°C for short-term active laboratory testing.
To preserve chemical integrity across long-term multi-week studies, stock solutions should be aliquoted immediately after initial reconstitution. Micro-aliquoting into sterile, low-protein-binding microcentrifuge tubes (e.g., 100 µL to 200 µL working aliquots) prevents repeated freeze-thaw cycles, which cause structural denaturation and variable assay activity.
Aliquoted tubes intended for extended storage should be flash-frozen and kept at -20°C or -80°C. Prior to use in downstream assays, individual aliquots should be thawed slowly on wet ice. Unused portions of thawed single-use aliquots should be discarded rather than re-frozen.
Quality Verification, Purity Standards, and Analytical Testing
Analytical accuracy in laboratory research relies on consistent purity and stoichiometric stability. At PX1 Research, every batch of KLOW Blend undergoes rigorous quality control standards to verify peptide identity, purity, mass balance, and sterility.
Purity is quantitatively established using High-Performance Liquid Chromatography (HPLC), guaranteeing that each component sequence meets or exceeds 99% chemical purity. Mass spectrometry (MS) confirms exact molecular weight profiles for GHK-Cu, TB-500, BPC-157, and KPV, eliminating batch-to-batch variations.
Furthermore, our compounds undergo Bacterial Endotoxin Testing (Chromogenic LAL Assay) to ensure endotoxin levels remain below strictly controlled research thresholds (< 0.05 EU/mg). Products are manufactured in ISO 17025 accredited and GMP-compliant facilities within the USA. Academic laboratories and commercial research entities seeking large-scale standardized batches can register for institutional access through our bulk research accounts portal.
Frequently Asked Questions
How much bacteriostatic water should I add to an 80mg KLOW Blend vial?
For most standard laboratory research protocols, adding 2.0 mL of bacteriostatic water to an 80 mg KLOW Blend vial yields a balanced concentration of 40 mg/mL total peptide mass (25 mg/mL GHK-Cu, 5 mg/mL TB-500, 5 mg/mL BPC-157, 5 mg/mL KPV). Volumes of 1.0 mL to 5.0 mL may be used depending on target assay sensitivity.
What is the concentration of each peptide in KLOW Blend after adding 2 mL of BAC water?
In a 2.0 mL reconstitution of an 80 mg KLOW Blend vial, the resulting concentrations are: GHK-Cu at 25 mg/mL, TB-500 at 5 mg/mL, BPC-157 at 5 mg/mL, and KPV at 5 mg/mL.
Can sterile water for injection be used instead of bacteriostatic water?
Sterile water lacks preservative agents (such as 0.9% benzyl alcohol) and should only be used if the reconstituted solution is consumed entirely in a single immediate assay transfer. For multi-use laboratory stock solutions stored over several days at 2°C–8°C, bacteriostatic water is required to inhibit microbial growth.
How long is reconstituted KLOW Blend stable in cold storage?
Reconstituted KLOW Blend prepared with bacteriostatic water remains chemically stable for up to 28 days when preserved at 2°C to 8°C. For longer preservation, reconstituted liquid should be aliquoted into low-binding tubes and stored at -20°C or -80°C.
Why is gentle swirling required instead of vortexing during reconstitution?
Vortexing or vigorous shaking introduces mechanical shear stress and air bubbles that can denature delicate peptide chains, disrupt structural folding, and cause protein aggregation. Gentle manual swirling ensures smooth dissolution without degrading sequence integrity.
What endotoxin levels are verified for PX1 Research KLOW Blend?
PX1 Research subjects every lot of KLOW Blend to rigorous Limulus Amebocyte Lysate (LAL) testing, guaranteeing endotoxin limits under < 0.05 EU/mg to prevent confounding inflammatory responses in sensitive cell culture models.
How can I calculate custom volumetric additions for specific cell culture wells?
Researchers can utilize the standard C1V1 = C2V2 dilution formula or access the PX1 Research online reconstitution calculator tool to determine exact microliter volumes required for targeted molar or mass concentrations.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.